B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?

ABSTRACT: B-cell acute lymphoblastic leukemia (B-ALL) is a hematologic malignancy that arises from the clonal expansion of transformed B-cell precursors and predominately affects childhood. Even though significant progresses have been made in the treatment of B-ALL, pediatric patients' outcome has to be furtherly increased and alternative targeted treatment strategies are required for younger patients. Over the last decade, novel approaches have been used to understand the genomic landscape and the complexity of the molecular biology of pediatric B-ALL, mainly next generation sequencing, offering important insights into new B-ALL subtypes, altered pathways, and therapeutic targets that may lead to improved risk stratification and treatments. Here, we will highlight the up-to-date knowledge of the no

SUBMITTER: Ratti S 

PROVIDER: S-EPMC7760974 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature